Introduction {#Sec1}
============

Chronic musculoskeletal pain and headaches are highly prevalent and they represent major health problems in most industrialised countries \[[@CR1], [@CR2]\]. Among such pain conditions tension-type headache (TTH) is the most prevalent primary headache \[[@CR2]\], while fibromyalgia (FMS) is a common and poorly understood cause of sick leave and disability in western countries \[[@CR3]\]. Different pain syndromes of unknown aetiology often share clinical features \[[@CR4], [@CR5]\] and several studies indicate that FMS and TTH have several common features, both with regard to pathophysiology, demographics and clinical symptoms, though there are also clear differences between the two conditions \[[@CR6], [@CR7]\]. One common feature for all these conditions is the patient's reports of stress as a trigger for the development of pain \[[@CR8], [@CR9]\]. Mental stress and especially stressful work situations have been related to development of pain in both musculoskeletal pain and headache \[[@CR10]--[@CR17]\].

Although there are many studies linking mental stress to headache and musculoskeletal pain, little solid evidence exists on the potential mechanisms for this. However, there are several theoretical models describing how stress may lead to disease and subjective complaints such as pain. One common denominator for these models is that they emphasise the lack of physiological recovery after stress as a risk factor for development of pain or other diseases \[[@CR18]--[@CR22]\]. Although studies investigating the physiological validity of these theoretical models are sparse \[[@CR23]\], there are some interesting findings. Reported "need for recovery after work" can increase the risk for cardiovascular disease \[[@CR24]\] and increase the risk for future sick leave \[[@CR25]\]. Work stress has also been linked to lower evening cortisol levels, interpreted as a sign of lack of recovery \[[@CR26]\]. Elevated blood pressure (BP) or peripheral vasoconstriction after stressful work may be a good indicator of prolonged arousal after stress, as our group has demonstrated that BP and finger skin blood flow (BF) responses to a stressful task lasts longer than other physiological stress responses \[[@CR27]\]. Sustained activation of physiological stress responses may potentially lead to a reduced dynamic capacity to respond to new stressors \[[@CR28]\]. Reduced physiological stress responses to different stressors have been found in both FMS and TTH, though results are conflicting \[[@CR29]--[@CR31]\].

We had previously studied the physiological and biochemical effects of experimentally induced cognitive stress on patients with migraine and TTH \[[@CR17], [@CR32], [@CR33]\], and on patients with FMS and chronic shoulder/neck pains (SNP) compared to controls \[[@CR16], [@CR34]\]. As many of the reported features in these diseases are overlapping, it was of interest to compare different pain syndromes of unknown aetiology to identify potential similarities and differences both in response and recovery to stress. The main hypothesis of the study was that patients with chronic pain (chronic TTH, FMS and SNP) had autonomic activity during and after a stressful task, distinguishing them from patients with less regular pain (migraine or episodic TTH) and healthy controls that have little or no pain.

Methods {#Sec2}
=======

Subjects {#Sec3}
--------

Totally, 44 healthy control subjects \[35 women (mean age 39.7 years) and 9 men (36.6 years)\] and 92 patients belonging to one of four diagnostic groups participated in this study. A total of 22 patients had migraine, 20 women (39.8 years) and 2 men (45.0 years), and 13 of these patients had aura preceding the headache. Eighteen patients had TTH, including nine women (33.8 years) and nine men (35.7 years). Twelve of the TTH patients had chronic TTH (daily headache) and six had episodic TTH (three patients reported 4--7 headache days per month and three patients reported 7--14 headache days per month). A total of 23 female patients were diagnosed with FMS (48.3 years), and 29 female patients (41.1 years) had SNP. Detailed subject and headache history data are shown in Table [1](#Tab1){ref-type="table"} (one migraine patient reported some attacks of short duration). Patients were diagnosed after an interview and physical examination by a neurologist or a specialist in physical medicine and rehabilitation. Headache diagnoses were made according to the International Headache Society classification of headache from 1988 \[[@CR35]\]. Migraineurs with TTH more than 7 days per month were excluded. FMS patients were included if they fulfilled the 1990 American College of Rheumatology criteria (ACR criteria) for FMS \[[@CR36]\]. SNP patients were included if they reported SNP (more than 3 months during previous year) with local tenderness or pain. SNP patients were included even if they reported pain in other body regions, as long as pain in the shoulder and neck region was their main problem. No SNP patients fulfilled the ACR criteria for FMS. Table 1Background data of subjects included in the studySubject groupGender ratio (F:M)Mean age (range)Mean general tension (VAS) (range)Controls (*n *= 44)35:939.0 (19--61)25.8 (0--84)Migraine (*n *= 22)20:240.2 (20--60)35.1 (1--87)Tension-type headache (*n *= 18)9:934.7 (19--52)25.1 (0--65)Fibromyalgia (*n *= 23)23:048.3 (32--63)47.3 (0--100)Chronic shoulder/neck pain (*n *= 29)29:041.1 (19--59)43.4 (8--89)Chronic pain patients (*n *= 64)59:442.9 (19--63)42.1 (0--100)Episodic pain patients/healthy controls (*n *= 72)57:1538.7 (19--61)28.0 (0--87)

Control subjects did not suffer from headache or musculoskeletal pain for more than 1 day per month. Exclusion criteria were: neoplastic disease, hypertension, infectious disease, metabolic, endocrine or neuromuscular diseases, significant psychiatric disorders, connective tissue disorder, tendinitis, recent significant accident or injury, pregnancy, daily medication with neuroleptics, antiepileptics, Ca^2+^-blockers, β-blockers, antidepressants and significant associated diseases affecting either the heart, lungs, cerebrovascular system, or the central or peripheral nervous system. The project was approved by the regional ethics committee. All participants gave written informed consent and received NOK 500 (USD 75) for transport expenses and inconvenience. The participants were provided with written information concerning the aim of the study prior to the day of the stress test. The aim of studying pain and headache was mentioned, but the information focused on the practical details of the procedure. Upon arrival on the test day, subjects went through a structured interview concerning headaches and musculoskeletal complaints (distribution, severity and duration). These data have been presented elsewhere and are not included in the present study \[[@CR16], [@CR17], [@CR32]--[@CR34]\].

Physiological recordings {#Sec4}
------------------------

Autonomic activity was measured indirectly by continuous recording of non-invasive finger BP (Portapres, TNO Biomedical Instrumentation, Amsterdam, The Netherlands) \[[@CR37]\] and skin BF in the thumbs (Moorlab, time constant 0.02 s, low-pass filter 22 kHz; Moor Instruments Ltd., Devon, England). The BP cuffs were mounted on the intermediate phalanx on the left middle and ring fingers. Finger skin BF was measured bilaterally with the electrodes (fibre separation 0.5 mm) placed on the volar side of the distal phalanx (pulp) of the thumbs. The average from the left and right thumb was used for analysis, because a significant side difference was not found. Signals were sampled at 200 Hz. Heart rate (HR) and BP were calculated with the Beatscope 1.0 software (TNO, Amsterdam, The Netherlands). Muscular activity was recorded with surface electromyography (EMG) bilaterally in the trapezius, splenius, temporalis and frontalis muscles, as described in a previous paper \[[@CR16], [@CR17]\]. Because we previously did not find differences in muscular activity between the controls and patients, these variables were not included in the statistical analyses in the present study. Respiration was recorded with a thermistor (Embla S-AF-010, Flaga, Reykjavik, Iceland) below the nose with active elements in each nostril and in front of the mouth, but respiration frequency was not analysed in this study due to technical difficulties (seven controls, eight migraine patients, two TTH patients, one FMS patient and two SNP patients had corrupted respiration rate data).

Procedure {#Sec5}
---------

The subjects were seated in an ordinary office chair without armrests and performed a two-choice reaction-time test presented on a PC monitor for 60 min \[[@CR38]\]. The test involved a grid (seven columns by five rows) in which a large and a small square were placed randomly \[[@CR39]\]. The subject was then presented with a suggestion on how to move the small square to superimpose it on the large square (for instance, "two up, four right"), and the subjects responded by pressing either "right" or "wrong" on a panel before them with their right index or ring finger, respectively. Then the positions of the squares were changed and a new suggestion was displayed. The subjects were instructed to carry out the assignment as fast and correctly as possible, and the computer provided feedback on performance by informing whether the answer was correct or not and how fast the trial was performed (very slow, slow, normal, fast or very fast) \[[@CR40]\]. The "normal" response for each subject was determined as the mean response time during a 5-min trial period. The subjects were acclimated to the lab environment for 30 min, during which the procedure was explained and the recording equipment was mounted. The recording started with 5 min uninstructed rest (UIR, baseline) followed by 5 min active, instructed rest with visual EMG feedback (FB). FB data were not included in the statistical analysis because we believe that UIR probably is a more realistic "real-life" baseline. The cognitive task was then performed for 1 h (800--1,500 trials), followed by 30 min recording during rest (recovery period). The subjects were asked to relax while seated and to move as little as possible during the recovery period. After the baseline and FB periods, at 10-min intervals during the cognitive task, and at 10-min intervals during the recovery period, the subjects were asked to mark on a 100 mm visual analogue scale (VAS) their level of pain with endpoints "no pain" and "worst imaginable pain". Pain was reported bilaterally in the trapezius, splenius, temporalis and frontalis areas. No patient had to be excluded because of headache attacks during the test. Venous blood was sampled before the test (immediately after the interview was concluded) and immediately after the stress period (after 60 min). Blood sample data will not be reported in this paper.

Some subjects had partly missing data due to technical difficulties: two controls, two migraine patients and four SNP patients had corrupted BP and HR data during the test and recovery period, and one patient with TTH had corrupted BP, HR, BF and pain data during the recovery period.

Data analysis {#Sec6}
-------------

Mean values for systolic blood pressure (SBP), diastolic blood pressure (DBP), HR and finger BF were calculated for the UIR period, and for each 10-min interval throughout the stressful task and recovery period. The pain variable used was defined as the maximal pain reported at the eight muscle locations (trapezius, splenius, temporalis and frontalis muscles; left and right side) at each 10-min interval. These data were used in statistical ANOVA models.

Baseline values were compared among the groups with Student's two-group *t* test. Repeated measures ANOVA time × group interaction was used to explore differences in response and recovery patterns between groups. It was the potential differences in response and recovery patterns to the stressor, which was of interest in the present study, and not differences in absolute levels, hence we report time × group interaction, *F* and *P* values. Three different models with selected dependent variables were applied to explore different parts of the stress response and recovery profile. To examine how the novelty of the stressor influenced the subjects, the first 10 min and the baseline were compared in an *F*~2~-model \[SBP, DBP, HR and BF: *y* = (baseline (UIR), 0--10 min); pain: *y* = (0, 10 min)\]. This was described as the early (acute) stress response. After the first 10 min, it was assumed that the novelty aspect of the stressor was gone, and we examined how the subjects adapted to the stressor with an *F*~6~ model with six repeated dependent variables \[SBP, DBP, HR and BF: *y* = (0--10, 10--20, 20--30, 30--40, 40--50, 50--60 min); pain: *y* = (10, 20, 30, 40, 50, 60 min)\] to examine how the subjects adapted to the stressor. This was described as the adaptation response to stress. An *F*~3~-model with three dependent variables \[*y* = (65--75, 75--85, 85--95 min)\] was used to examine how the subjects recovered from the stressor. For pain, recovery was evaluated with an *F*~4~-model with four dependent variables \[*y* = (65, 75, 85, 95 min). An *F*~4~-model instead of an *F*~3~-model was necessary for the pain variable to cover the same time frame as the physiological variables, since pain was measured every 10 min and not as an average of continuously measured 10-min intervals. The ANOVA models were corrected for non-sphericity by reduced degrees of freedom with Huyhn--Feldts method. In the present study, we report differences in migraine and TTH patients compared to FMS and SNP patients. Differences in TTH patients compared to migraine patients and healthy controls, and differences in FMS patients compared to SNP patients and healthy controls have been reported in previous papers \[[@CR16], [@CR17], [@CR32]--[@CR34]\].

As FMS and SNP and, to some extent, TTH are associated with chronic pains, and based on observations made in earlier studies, it was of interest to compare subjects with chronic pain (12 chronic TTH, FMS and SNP patients) against subjects with episodic or no pain (controls, migraine and six episodic TTH patients). The basis for this grouping was that the episodic pain patients are pain-free most of the time. It was also of interest to investigate whether headache patients as a group were different from patients with musculoskeletal pains. Therefore, *F*~2~, *F*~6~ and *F*~3~/*F*~4~ analyses were performed both on chronic pain patients versus non-chronic/healthy subjects, and on headache patients versus musculoskeletal pain patients.

As our general statistical strategy involves a large number of comparisons, some might argue that there is a need for a multiple-comparison adjustment to control for type I errors. We chose not to do this, as this would create other problems, such as an increase in type II errors \[[@CR41], [@CR42]\]. Also, as the study was considered to be mainly hypothesis-generating and not so much hypothesis-controlling, we believe that findings worthy of further research might be missed by applying too rigid criteria to the statistical analyses. A two-tailed significance level of \<0.05 was considered significant in the statistical analyses. *P* values within a range of 0.05--0.10 were defined as trends.

Results {#Sec7}
=======

Comparison of baseline, early test response patterns and test adaptation {#Sec8}
------------------------------------------------------------------------

There were no differences in SBP, DBP, HR or BF baseline values among the groups (*P* ≥ 0.149; Fig. [1](#Fig1){ref-type="fig"}a--d). Baseline pain was found to be higher in FMS patients compared to migraine patients (*P* \< 0.0005; Fig. [1](#Fig1){ref-type="fig"}e) and TTH patients (*P* = 0.037) and tended to be higher in SNP patients compared to migraine patients (*P* = 0.054). When comparing the early response patterns (*F*~2~; Table [2](#Tab2){ref-type="table"}; Fig. [1](#Fig1){ref-type="fig"}a--e), a significant difference in early HR response caused by a lower initial increase in HR was found in FMS compared to migraine patients (*F*~2~ = 7.33, *P* = 0.01; Fig. [1](#Fig1){ref-type="fig"}c), while no difference was found between FMS and TTH. Fig. 1Development of systolic BP (**a**), diastolic BP (**b**), heart rate (**c**) finger blood flow (**d**) and pain (**e**) throughout the stressful task and recovery period in patients with migraine, TTH, FMS and SNP. Values are given as group means (SEM). UIR: uninstructed rest period (baseline EMG). 0--60 min: duration of the cognitive stressful task. 65--95 min: relaxation period after the testTable 2Early response (*F*~2~), adaptation during stress (*F*~6~) and recovery from stress (*F*~3~/*F*~4~)Migraine versus FMSMigraine versus SNPTTH versus FMSTTH versus SNPChronic pain patients versus episodic pain patients and controlsHeadache patients versus musculoskeletal pain patientsSystolic blood pressure*F*~2~ = 2.39, *P* = 0.13*F*~2~ = 0.18, *P* = 0.67*F*~2~ = 0.19, *P* = 0.67*F*~2~ = 0.45, *P* = 0.51*F*~2~ = 0.59, *P* = 0.45*F*~2~ = 0.35, *P* = 0.56*F*~6~ = 2.23, *P* = 0.079*F*~6~ = 1.45, *P* = 0.23*F*~6~ = 0.20, *P* = 0.93*F*~6~ = 0.31, *P* = 0.83***F***~**6**~** = 2.94,*P* = 0.028***F*~6~ = 0.66, *P* = 0.59*F*~3~ = 0.005, *P* = 0.995*F*~3~ = 0.48, *P* = 0.59*F*~3~ = 0.56, *P* = 0.55*F*~3~ = 1.21, *P* = 0.30*F*~3~ = 0.40, *P* = 0.66*F*~3~ = 0.81, *P* = 0.44Diastolic blood pressure*F*~2~ = 1.19, *P* = 0.28*F*~2~ = 0.28, *P* = 0.59*F*~2~ = 0.02, *P* = 0.88*F*~2~ = 0.32, *P* = 0.57*F*~2~ = 1.37, *P* = 0.25*F*~2~ = 0.26, *P* = 0.61*F*~6~ = 1.89, *P* = 0.14*F*~6~ = 1.03, *P* = 0.39*F*~6~ = 0.44, *P* = 0.77*F*~6~ = 0.31, *P* = 0.87***F***~**6**~** = 2.72,*P* = 0.036***F*~6~ = 0.99, *P* = 0.41*F*~3~ = 0.66, *P* = 0.51*F*~3~ = 1.17, *P* = 0.31*F*~3~ = 0.57, *P* = 0.54*F*~3~ = 1.44, *P* = 0.24*F*~3~ = 0.57, *P* = 0.53*F*~3~ = 1.70, *P* = 0.20Heart rate***F***~**2**~** = 7.33,*P* = 0.01***F*~2~ = 2.8, *P* = 0.10*F*~2~ = 0.78, *P* = 0.38*F*~2~ = 0.02, *P* = 0.90***F***~**2**~** = 9.80,*P* = 0.002***F*~2~ = 3.39, *P* = 0.07*F*~6~ = 1.15, *P* = 0.33*F*~6~ = 0.43, *P* = 0.65*F*~6~ = 2.05, *P* = 0.11*F*~6~ = 1.42, *P* = 0.25*F*~6~ = 2.58, *P* = 0.075*F*~6~ = 1.02, *P* = 0.37*F*~3~ = 0.74, *P* = 0.48*F*~3~ = 0.26, *P* = 0.77*F*~3~ = 0.38, *P* = 0.69*F*~3~ = 0.005, *P* = 0.995*F*~3~ = 0.28, *P* = 0.76*F*~3~ = 0.29, *P* = 0.75Finger skin blood flow*F*~2~ = 0.17, *P* = 0.68*F*~2~ = 0.004, *P* = 0.95*F*~2~ = 0.16, *P* = 0.69*F*~2~ = 0.001, *P* = 0.98*F*~2~ = 0.44, *P* = 0.51*F*~2~ = 0.08, *P* = 0.78***F***~**6**~** = 3.43,*P* = 0.021***F*~6~ = 1.29, *P* = 0.28*F*~6~ = 2.52, *P* = 0.072*F*~6~ = 0.63, *P* = 0.59***F***~**6**~** = 3.93,*P* = 0.012*F***~**6**~** = 3.15,*P* = 0.028***F*~3~ = 3.27, *P* = 0.05***F***~**3**~** = 4.99,*P* = 0.01***F*~3~ = 0.03, *P* = 0.94*F*~3~ = 0.05, *P* = 0.95***F***~**3**~** = 4.93,*P* = 0.01***F*~3~ = 2.39, *P* = 0.10Maximal pain*F*~2~ = 2.75, *P* = 0.105*F*~2~ = 2.10, *P* = 0.15*F*~2~ = 0.12, *P* = 0.73*F*~2~ \< 0.0005, *P* = 0.99***F***~**2**~** = 4.01,*P* = 0.047***F*~2~ = 1.46, *P* = 0.23*F*~6~ = 1.02, *P* = 0.38*F*~6~ = 0.70, *P* = 0.54***F***~**6**~** = 3.25,*P* = 0.025*F***~**6**~** = 3.10,*P* = 0.033***F*~6~ = 0.52, *P* = 0.65*F*~6~ = 0.90, *P* = 0.44*F*~4~ = 0.23, *P* = 0.75*F*~4~ = 1.18, *P* = 0.31*F*~4~ = 0.21, *P* = 0.79*F*~4~ = 0.57, *P* = 0.61*F*~4~ = 0.75, *P* = 0.46*F*~4~ = 0.73, *P* = 0.48*F*-statistics shown for group × time interactions in two-group repeated measures ANOVA models*FMS* fibromyalgia syndrome, *SNP* shoulder/neck pain, *TTH* tension-type headache*F*~2~ repeated measures ANOVA model with two intervals during the early stage of the stressful task (baseline and 0--10 min), *F*~6~ model with six intervals during the stressful task (0--60 min), *F*~3~/*F*~4~ model with three intervals (four intervals for pain) during recovery (65--95 min), *P* probabilities were adjusted for non-sphericity with Huyhn--Feldt's method. Significant interactions in bold

Migraine patients were significantly different from FMS patients with less increase in vasoconstriction measured by finger BF during the test (*F*~6~ = 3.43, *P* = 0.021; Table [2](#Tab2){ref-type="table"} and Fig. [1](#Fig1){ref-type="fig"}d), while the difference between TTH and FMS patients was not significant. We also found a trend towards a different SBP adaptation during the test in migraine patients compared to FMS patients (*F*~6~ = 2.23, *P* = 0.079; Fig. [1](#Fig1){ref-type="fig"}a), with a continued SBP increase in FMS while migraine patients stabilized or dropped slightly in SBP. The corresponding difference between TTH and FMS was not significant. It was also found that TTH patients had a larger increase in pain compared to FMS (*F*~6~ = 3.25, *P* = 0.025) and SNP patients (*F*~6~ = 3.10, *P* = 0.033; Fig. [1](#Fig1){ref-type="fig"}E).

Comparison of recovery patterns {#Sec9}
-------------------------------

Looking at the recovery patterns (*F*~3~ and *F*~4~; Table [2](#Tab2){ref-type="table"}), we found a significantly less decreasing BF recovery profile in migraineurs compared to SNP patients (*F*~3~ = 4.99, *P* = 0.01, Fig. [1](#Fig1){ref-type="fig"}d), and a similar trend towards a difference in migraineurs compared to FMS patients (*F*~3~ = 3.27, *P* = 0.05). Other cardiovascular and pain recovery patterns in TTH patients were similar to FMS and SNP patients (*F*~3,\ 4~ ≤ 1.44, *P* ≥ 0.24; Fig. [1](#Fig1){ref-type="fig"}a--e).

Chronic pain patients versus controls and migraineurs {#Sec10}
-----------------------------------------------------

We also made a comparison of the patients with chronic pain, i.e. FMS, SNP and the 12 TTH patients with chronic pain (Table [1](#Tab1){ref-type="table"}), compared to non-chronic subjects (migraine, episodic TTH and controls grouped together; Fig. [2](#Fig2){ref-type="fig"}a--e). SBP and DBP profiles increased more throughout the test and there was more increase in vasoconstriction (i.e. less skin BF) in chronic pain patients compared to non-chronic subjects (*F*~6~ ≥ 2.72, *P* ≤ 0.036; Table [2](#Tab2){ref-type="table"}). There was also less increase in the early HR response (*F* = 9.8, *P* = 0.002) and the HR adaptation profile tended to decrease less throughout the stressful task for chronic pain patients (*F*~6~ = 2.58, *P* = 0.075, Fig. [2](#Fig2){ref-type="fig"}a--d). Chronic pain patients also had a less increasing *F*~2~ pain profile during the early phase of the stressful task (*F* = 4.01, *P* = 0.047; Fig. [2](#Fig2){ref-type="fig"}e). Fig. 2Development of systolic BP (**a**), diastolic BP (**b**), heart rate (**c**) finger blood flow (**d**) and pain (**e**) throughout the stressful task and recovery period in chronic pain patients (chronic TTH, FMS and SNP) and episodic pain/no pain subjects (episodic TTH, migraine and controls). Values are given as group means (SEM). UIR: uninstructed rest period (baseline EMG). 0--60 min: duration of the cognitive stressful task. 65--95 min: relaxation period after the test

When investigating recovery from stress, chronic pain patients had a significantly less BF recovery compared to non-chronic subjects (*F*~3~ = 4.93, *P* = 0.01; Table [2](#Tab2){ref-type="table"}; Fig. [2](#Fig2){ref-type="fig"}d). BP and HR profiles were not different.

Headache patients versus patients with musculoskeletal pain {#Sec11}
-----------------------------------------------------------

When we compared headache patients and musculoskeletal pain patients, a significantly larger increase in vasoconstriction was found in musculoskeletal pain patients compared to headache patients during the test (*F*~6~ = 3.15, *P* = 0.028; Table [2](#Tab2){ref-type="table"}). In addition, musculoskeletal pain patients had a trend towards less increase in HR during the first 10 min of the stressful task compared to headache patients (*F*~2~ = 3.39, *P* = 0.07).

Discussion {#Sec12}
==========

The present study is to our knowledge the first to compare cardiovascular and pain responses and recovery during and after low-grade cognitive stress in FMS and TTH patients. It is of interest that no significant differences in BP, HR or BF responses to a mental stressor or recovery thereafter were found between TTH and FMS patients. In contrast, less increase in vasoconstriction during the stressful task was found in migraineurs compared to FMS patients. FMS patients also had a significantly lower early HR response compared to migraine patients. The similarities between TTH, FMS and SNP are interesting, as are the differences between these patients and migraine patients. Headaches and chronic musculoskeletal pain disorders are comorbid conditions \[[@CR43]\], and a few earlier studies also suggest that TTH and FMS share some pathophysiological characteristics, but also that there are differences in the two diagnoses \[[@CR6], [@CR7]\]. Most of the studies have focused on pain physiology and muscle activity, as well as clinical features and epidemiological aspects.

The BF recovery in TTH, FMS and SNP patients all differed from migraine patients, suggesting that a common mechanism may explain at least the relative lack of BF recovery in these patients compared to migraine patients and controls \[[@CR32], [@CR34]\]. BP profiles were also similar among TTH, FMS and SNP patients, but they were not significantly different from those of migraineurs, although the curves in Fig. [1](#Fig1){ref-type="fig"}a--b appeared to be different.

The early HR response in FMS patients was different from that of migraineurs, and our group has previously also reported that the early HR response in FMS patients are different compared to controls \[[@CR34]\]. A reduced HR response to stress in FMS patients has also been reported in several other studies \[[@CR44]--[@CR49]\], and some studies suggest a connection between a reduced stress response and the hyperalgesic state in FMS patients \[[@CR29], [@CR34], [@CR50], [@CR51]\]. While TTH and SNP were not statistically different from either migraine or FMS \[[@CR32], [@CR34]\] with regard to the early HR response (Table [2](#Tab2){ref-type="table"}), there was a significant difference in the early HR response between chronic and non-chronic/healthy subjects (Fig. [2](#Fig2){ref-type="fig"}c; Table [2](#Tab2){ref-type="table"}) suggesting that TTH and SNP are similar to FMS. We have previously suggested that TTH patients have a reduced or "blunted" response to stress, evident by a lack of an initial "spiked" response and followed by a more or less constant HR throughout the stress period \[[@CR32]\]. However, our results indicate that there is no general relation between a low HR stress response and pain, as it is only the FMS patients who have a significant correlation between the HR response and pain development during the stressful task \[[@CR34]\].

FMS patients had more vasoconstriction in skin blood vessels compared to migraineurs, both during and after the stressful task, while SNP (and TTH \[[@CR32]\]) had more vasoconstriction only during the recovery period. One may speculate that this is a pain-induced phenomenon, as all three groups had more pain than the migraine patients, but no clear correlation between pain and BF was found (results not shown). Sympathetic dysregulation of skin BF would be an alternative hypothesis, for instance through central autonomic hyperactivity or hypersensitivity. However, as sympathetic activity influences BP, HR and BF, it is difficult to understand why skin BF should differ more between these groups than the other cardiovascular variables. A possible reason may be that while BF regulation in the finger skin is mediated mainly by sympathetic activity \[[@CR52]\], BP and HR are mediated in a more complex way by both sympathetic and parasympathetic activity \[[@CR53]\]. In addition, it is known that autonomic vasomotor activity in different organs is regulated individually, according to the functional needs of each organ \[[@CR54]--[@CR56]\].

Although autonomic response profiles were similar on comparing TTH, FMS and SNP patients, TTH patients had a much higher increase in pain during the test than both FMS and SNP patients, the latter groups being comparable to migraine patients and controls in this respect \[[@CR17]\]. The larger increase in pain observed in TTH patients compared to the other patient groups may be interpreted as a "pain potentiation" reflecting increased temporal summation of pain, which is normally associated with central sensitisation. Central sensitisation has previously been suggested to be important not only in TTH \[[@CR57]--[@CR63]\], FMS and SNP \[[@CR16], [@CR64], [@CR65]\], but also in migraine \[[@CR66]--[@CR68]\]. Our study suggests that TTH patients respond to stress with a much higher increase in pain than the other patients, but we have no data to determine whether this is due to differences in pain processing at a central or peripheral level.

On performing the same statistical analyses for chronic pain patients versus non-chronic subjects, as we did for the individual subject groups, we found differences between the groups that were not apparent when analysing differences between diagnostic groups. First of all, SBP, DBP and BF profiles during the stressful task were all different in chronic pain patients compared to migraineurs and controls, with the BP early responses being somewhat lower and continuing to increase throughout the test in the chronic group. Finger BF during the stressful task decreased more (i.e. more vasoconstriction) in the chronic group compared to the non-chronic group. Differentiating subjects by pain location (headache vs. musculoskeletal pain) did not provide any results not already found during the primary analyses on individual diagnoses. This indicates that subdividing the patients into groups based on the temporal pain patterns (chronic pain vs. episodic pain) results in a more homogenous group regarding the physiological responses to and recovery from low-grade cognitive stress, than if the subdivision is made based on anatomical pain location. This suggests that chronic pain patients have some stress-induced autonomic features in common.

In the recovery period, FMS and SNP patients had more vasoconstriction than migraine patients. Previously, we had reported increased vasoconstriction in TTH patients compared to migraine patients in the recovery period after stress \[[@CR32]\]. Chronic pain patients also continued to have decrease in BF during the recovery period, while the episodic pain/control group seemed to stabilise. This finding is especially interesting in conjunction with the theoretical models of Eriksen and Ursin \[[@CR19], [@CR20]\] and McEwen \[[@CR21], [@CR22]\]. Both these models focus on subjects' inability to turn off a stress response, i.e. a lack of recovery, as a cause of health complaints. Repeated inability to recover from stress, for instance caused by the subject's inability to cope with the demands in his/her working environment, may create a vicious circle resulting in pain or other health complaints in some subjects. This model is supported by a study of Sluiter et al., who reported a connection between the need for recovery from work-related fatigue (presumably caused by stress and other work-environmental factors) and subjective health complaints \[[@CR69]\]. TTH, FMS and SNP patients are often considered to be more sensitive to stress than healthy people and may thus be unable to mount a successful defence mechanism against stress, resulting in increased pain and prolonged physiological responses as seen from the reduced BF recovery among these patients in the present study. However, it must be emphasised that the present study does not provide evidence for a causal relation between the lack of BF recovery and pain development, but rather that these patients have an inability to recover from stress.

In conclusion, analyses of groups differentiated by pain chronicity indicated that cardiovascular stress responses, such as BP, HR and BF development, are similar among chronic TTH, FMS and SNP patients and different from that of migraine patients, episodic TTH patients and healthy controls, both during and after a stressful task. This suggests that these three chronic pain conditions may share some physiological mechanisms. Whether these mechanisms are causally related to pain, or just reflections of the chronic pain state, cannot be determined from the present study. As this is the first study that compares these patient groups in a long-lasting stress model, the results need confirmation from studies with similar methods. If confirmed, these findings may provide deeper insight into pathophysiological mechanisms and may improve treatment or prevention of these very prevalent and costly disorders.
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